Nuformix (LSE:NFX) Other Gross PPE : £0.00 Mil (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Other Gross PPE?

Nuformix's Other Gross PPE for the quarter that ended in Sep. 2022 was £0.00 Mil.

Nuformix's annual Other Gross PPE declined from Mar. 2020 (£0.13 Mil) to Mar. 2021 (£0.00 Mil) but then stayed the same from Mar. 2021 (£0.00 Mil) to Mar. 2022 (£0.00 Mil).

Nuformix Other Gross PPE Historical Data

The historical data trend for Nuformix's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Other Gross PPE Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Other Gross PPE

Get a 7-Day Free Trial

0.01

0.04

0.13

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Other Gross PPE	Get a 7-Day Free Trial									-	-	-	-	-

Nuformix Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.